Online Mindfulness-based Tic Reduction (Phase Two)
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Psychiatric, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/13/2018 |
| Start Date: | November 9, 2018 |
| End Date: | May 30, 2021 |
| Contact: | Hannah Reese, Ph.D. |
| Email: | hreese@bowdoin.edu |
| Phone: | 207-798-4146 |
Online Mindfulness-based Tic Reduction: Development and Testing (Phase Two)
Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially
disabling neurobiological conditions. Although a range of pharmacological and psychosocial
treatments exists, a significant number of individuals either do not respond to the current
treatments or find them unacceptable. Thus, it is essential that researchers continue to
develop and test novel treatment approaches.
In this randomized controlled trial the investigators will compare two different online
group-based interventions for tics: a mindfulness-based program (Mindfulness-based
Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic
Information and Coping Strategies (TICS)). The purpose of this study is to determine which
intervention is more helpful for adults with a tic disorder.
disabling neurobiological conditions. Although a range of pharmacological and psychosocial
treatments exists, a significant number of individuals either do not respond to the current
treatments or find them unacceptable. Thus, it is essential that researchers continue to
develop and test novel treatment approaches.
In this randomized controlled trial the investigators will compare two different online
group-based interventions for tics: a mindfulness-based program (Mindfulness-based
Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic
Information and Coping Strategies (TICS)). The purpose of this study is to determine which
intervention is more helpful for adults with a tic disorder.
Inclusion Criteria:
1. be 18 years of age or older,
2. possess a primary diagnosis of Tourette Syndrome or Persistent Tic Disorder,
3. be fluent in English
4. reside in the United States,
5. either not be taking any tic suppressant medication or other psychotropic medication
or be at a stable dose for 8 weeks prior to the baseline assessment and throughout the
study
Exclusion Criteria:
1. be receiving concurrent psychotherapy for the duration of the study
2. have prior extensive experience with mindfulness and/or meditation and
3. have another medical or psychological condition that would prevent the individual from
fully engaging in the study or require a higher level of care (e.g., suicidality).
We found this trial at
2
sites
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-4354
Click here to add this to my saved trials
Click here to add this to my saved trials